Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.

By B. Psaty, Thomas Lumley, C. Furberg, Gina D. Schellenbaum, Marco Pahor, M. Alderman, N. Weiss. Journal of the American Medical Association (JAMA), 2003

1,110 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/470af114391cb58325e2e8e1f722b7dc545be30b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. A. Ades
2. C. Bushnell
3. C. Iadecola
4. M. Creager

Citations in the corpus

• Standards of Medical Care in Diabetes—2008 (2008, result): “However, a variety of other studies have shown no specific advantage to ACE inhibitors as initial treatment of hypertension in the general hypertensive population, but rather an advantage on cardiovascular outcomes of initial therapy with low-dose thiazide diuretics (130, 142,143).”
• Guidelines for the Primary Prevention of Stroke (2011, positive): “004) compared with no drug treatment.(230) The use of antihypertensive therapies among those with mild hypertension (SBP, 140 to 159 mm Hg; DBP, 90 to 99 mm Hg; or both), however, was not clearly shown to reduce the risk of first stroke in a Cochrane Database Systematic Review, although a trend of c”